U S Global Investors Inc Abb Vie Inc. Transaction History

U S Global Investors Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $337,635 - $405,934	-5,361 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$65.7 - $83.98 $606,213 - $774,883	-9,227 Reduced 63.25%	5,361 $390,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $280,095 - $329,658	-3,631 Reduced 19.93%	14,588 $1.18 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $1.08 Million - $1.33 Million	13,830 Added 315.11%	18,219 $1.68 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $390,225 - $433,808	4,389 New	4,389 $415,000
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $1.91 Million - $2.1 Million	-21,363 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $440,054 - $562,086	-6,300 Reduced 22.77%	21,363 $1.9 Million
Q2 2017 Aug 17, 2017	BUY	N/A	27,663	27,663 $2.01 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of U S Global Investors Inc, based on Form 13F filings with the SEC.

Stay updated on U S Global Investors Inc with notifications on news.